Barbara Klencke - Insider Trading & Ownership

Entity
Individual
Location
C/O Sierra Oncology, Inc., 1820 Gateway Drive, Suite 110, San Mateo, California
Summary
The estimated net worth of Barbara Klencke is at least $414 K dollars as of June 17, 2024. Barbara Klencke is the Director of TScan Therapeutics, Inc. and owns shares of TScan Therapeutics, Inc. (TCRX) stock worth about $273 K. Barbara Klencke is the Director of Xencor Inc and owns shares of Xencor Inc (XNCR) stock worth about $141 K.
All Insider Reports
All Insider Reports

Ownership of Barbara Klencke

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TCRX TScan Therapeutics, Inc. Director $273 K +$25.4 K +10.2% Jun 12, 2024
XNCR Xencor Inc Director $141 K Jun 13, 2024
EFTR, EFTRW eFFECTOR Therapeutics, Inc. Director Jun 13, 2024
SRRA Sierra Oncology, Inc. Chief Medical Officer Jul 1, 2022

Insider Transactions Reported by Barbara Klencke:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership